GlassScriptPhysician profile
Hannah Rossi
NPI 1861122764
$617.93
in general payments reported to CMS, 2019-2025
14 companies · $103 in 2025
The $103 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $68.69 · 2023: $265 · 2024: $181 · 2025: $103.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $549.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $549.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $125.11 | 2022-2025 | Bexsero, Rotarix, Pediarix |
| Ironshore Pharmaceuticals INC. | $117.91 | 2023-2024 | Jornay Pm |
| Corium, LLC | $71.69 | 2022-2023 | Azstarys |
| Merck Sharp & Dohme LLC | $52.89 | 2022-2025 | Gardasil 9, Gardasil, Vaxelis |
| Sanofi Pasteur INC. | $51.95 | 2023-2024 | |
| Abbvie INC. | $41.65 | 2022-2023 | |
| Acadia Pharmaceuticals INC | $30.67 | 2025 | Daybue |
| Kowa Pharmaceuticals America, INC. | $22.37 | 2025 | Zoryve |
| Supernus Pharmaceuticals, INC. | $19.34 | 2024 | Qelbree |
| Sanofi-Aventis U.S. LLC | $18.99 | 2025 | |
| Verrica Pharmaceuticals INC. | $18.64 | 2024 | Ycanth |
| Pfizer INC. | $16.62 | 2024 | |
| Phadia US INC. | $16.11 | 2023 | Immunocap |
| Monteris Medical Corporation | $13.99 | 2024 | Neuroblate |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hannah Rossi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.